LOUISVILLE, Ky., March 03, 2017 -- Almost Family, Inc. (Nasdaq:AFAM), a leading regional provider of home health nursing and personal care services, announced today that it will report financial results for its fourth quarter and full year 2016 on Tuesday, March 7, 2017, publishing an earnings release after the market closes.
About Almost Family, Inc.
Almost Family, Inc., founded in 1976, is a leading national provider of home healthcare services, with 340 branch locations in 26 states. Almost Family, Inc. and its subsidiaries operate a visiting nurse segment, a personal care segment and a Healthcare Innovations segment.
Almost Family, Inc. Steve Guenthner President and Principal Financial Officer Investor Relations (502) 891-1000


L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 



